Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00312936 · ClinicalTrials.gov registry record · Phase 1
A Mindfulness Based Approach to HIV Treatment Side Effects
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 76
- Enrollment target
NCT00312936 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 76 participants.
The verdict
NCT00312936, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 76 participants
- Enrollment target
Study Summary
We are exploring the effect that an 8 week stress reduction program based in mindfulness practices will have on the experience of medication side effects reported by HIV-infected men and women taking antiretroviral therapy.
Interventions
- BEHAVIORAL Mindfulness-based Stress Reduction (MBSR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00312936
The ClinicalTrials.gov registry entry for NCT00312936 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness-based Stress Reduction (MBSR) is the first listed.
NCT00312936 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00312936 about?
NCT00312936 is a clinical study titled "A Mindfulness Based Approach to HIV Treatment Side Effects". We are exploring the effect that an 8 week stress reduction program based in mindfulness practices will have on the experience of medication side effects reported by HIV-infected men and women taking antiretroviral therapy.
What is the current status of trial NCT00312936?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 76 participants. The study started on 2006-07. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00312936?
The interventions under investigation include: Mindfulness-based Stress Reduction (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00312936?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.